Literature DB >> 26722309

miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation.

X U Zhou1, Lin Qi1, Shiyu Tong1, Y U Cui1, Jinbo Chen1, Tianxiang Huang2, Zhi Chen1, Xiong-Bing Zu1.   

Abstract

MicroRNA-128 (miR-128) serves an important role in regulating growth, invasiveness, stem cell-like traits, differentiation and apoptosis of different types of tumor cells. Vascular endothelial growth factor-C (VEGF-C) has been associated with angiogenesis, lymphangiogenesis and regional lymph node metastasis and has previously been reported to have an anti-apoptotic and proliferative role in bladder cancer (BC). To investigate the regulation of miR-128 on VEGF-C expression and their effects on proliferation and metastasis of bladder cancer, T24 and 5637 BC cells were transfected with pre-miR-128, anti-miR-128 and their respective negative control. miR-128 was downregulated in BC tissues and cell lines, while the expression levels of VEGF-C were upregulated. The present results indicated that miR-128 negatively regulated VEGF-C expression in BC T24 and 5637 BC cells. VEGF-C is a direct target of miR-128 in BC cells. Overexpression of miR-128 inhibited cell proliferation, migration and invasion. Knockdown of miR-128 promoted proliferation, migration and invasion in BC cells. Therefore, downregulation mediated malignant progression of BC may be partly attributed to increased VEGF-C expression. Consequently, the findings of the present study provide a molecular basis for the role of miR-128/VEGF-C in the progression of human BC and indicate a novel target for treatment of BC.

Entities:  

Keywords:  bladder cancer; metastasis; miR-128; vascular endothelial growth factor-C

Year:  2015        PMID: 26722309      PMCID: PMC4665335          DOI: 10.3892/ol.2015.3689

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Cell Mol Life Sci       Date:  2010-09-19       Impact factor: 9.261

2.  MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.

Authors:  Lei Shen; Xiao-Dong Chen; Yao-Hui Zhang
Journal:  Tumour Biol       Date:  2013-10-15

3.  CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

Authors:  Jonathan B Overdevest; Shibu Thomas; Glen Kristiansen; Donna E Hansel; Steven C Smith; Dan Theodorescu
Journal:  Cancer Res       Date:  2011-04-11       Impact factor: 12.701

4.  Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.

Authors:  Yusuke Takahashi; Takeshi Iwaya; Genta Sawada; Junji Kurashige; Tae Matsumura; Ryutaro Uchi; Hiroki Ueo; Yuki Takano; Hidetoshi Eguchi; Tomoya Sudo; Keishi Sugimachi; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori; Koshi Mimori
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

5.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Authors:  Cristina Evangelisti; Maria Carolina Florian; Isabella Massimi; Carlo Dominici; Giuseppe Giannini; Silvia Galardi; Maria Cristina Buè; Simone Massalini; Heather P McDowell; Elio Messi; Alberto Gulino; Maria Giulia Farace; Silvia Anna Ciafrè
Journal:  FASEB J       Date:  2009-08-27       Impact factor: 5.191

8.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Shanté Williams; Akihiro Otsuki; Gerard Nuovo; Abhik Raychaudhury; Herbert B Newton; E Antonio Chiocca; Sean Lawler
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

9.  MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.

Authors:  Zhu-mei Shi; Jing Wang; Zhiping Yan; Yong-ping You; Chong-yong Li; Xu Qian; Yu Yin; Peng Zhao; Ying-ying Wang; Xie-feng Wang; Ming-na Li; Ling-Zhi Liu; Ning Liu; Bing-Hua Jiang
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma.

Authors:  Zheng Tian; Bin Guo; Mei Yu; Chong Wang; Haoshaqiang Zhang; Qingfu Liang; Kunli Jiang; Li Cao
Journal:  Onco Targets Ther       Date:  2014-09-15       Impact factor: 4.147

View more
  23 in total

1.  miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.

Authors:  Yi Xiao; Changliang Su; Taoran Deng
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

2.  MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.

Authors:  Yong-Hao Nan; Jun Wang; Yao Wang; Peng-Hao Sun; Yu-Ping Han; Li Fan; Kai-Chen Wang; Fu-Jun Shen; Wei-Hua Wang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  HIV-infection and cocaine use regulate semen extracellular vesicles proteome and miRNAome in a manner that mediates strategic monocyte haptotaxis governed by miR-128 network.

Authors:  Hussein Kaddour; Steven Kopcho; Yuan Lyu; Nadia Shouman; Victor Paromov; Siddharth Pratap; Chandravanu Dash; Eun-Young Kim; Jeremy Martinson; Heather McKay; Marta Epeldegui; Joseph B Margolick; Jack T Stapleton; Chioma M Okeoma
Journal:  Cell Mol Life Sci       Date:  2021-12-22       Impact factor: 9.207

4.  MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.

Authors:  Xuefeng He; Jigen Ping; Duangai Wen
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

5.  LncRNA DANCR regulates lymphatic metastasis of bladder cancer via the miR-335/VEGF-C axis.

Authors:  Qinrong Ping; Yunqiang Shi; Meng Yang; Hui Li; Yiming Zhong; Jian Li; Xiaofang Bi; Chunhui Wang
Journal:  Transl Androl Urol       Date:  2021-04

Review 6.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

7.  Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.

Authors:  Andrea Coccia; Luciana Mosca; Rosa Puca; Giorgio Mangino; Alessandro Rossi; Eugenio Lendaro
Journal:  Oncol Rep       Date:  2016-10-05       Impact factor: 3.906

Review 8.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

9.  Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells.

Authors:  Chih-Yang Lin; Shih-Wei Wang; Yen-Ling Chen; Wen-Yi Chou; Ting-Yi Lin; Wei-Cheng Chen; Chen-Yu Yang; Shih-Chia Liu; Chia-Chu Hsieh; Yi-Chin Fong; Po-Chuan Wang; Chih-Hsin Tang
Journal:  Cell Death Dis       Date:  2017-08-03       Impact factor: 8.469

10.  MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.

Authors:  Dejian Zhao; Wenzheng Han; Xia Liu; Dawei Cui; Yu Chen
Journal:  Thorac Cancer       Date:  2017-05-17       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.